About endra life sciences inc - NDRA
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.
NDRA At a Glance
ENDRA Life Sciences, Inc.
3600 Green Court
Ann Arbor, Michigan 48105-1570
| Phone | 1-734-335-0468 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -7,027,410.00 | |
| Sector | Health Technology | Employees | 11 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
NDRA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 2.358 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.588 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.149 |
NDRA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -638,855.455 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
NDRA Liquidity
| Current Ratio | 1.289 |
| Quick Ratio | 1.289 |
| Cash Ratio | 1.015 |
NDRA Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -169.21 |
| Return on Equity | -291.564 |
| Return on Total Capital | -255.313 |
| Return on Invested Capital | -247.839 |
NDRA Capital Structure
| Total Debt to Total Equity | 21.784 |
| Total Debt to Total Capital | 17.888 |
| Total Debt to Total Assets | 12.776 |
| Long-Term Debt to Equity | 16.06 |
| Long-Term Debt to Total Capital | 13.187 |